Quick Answer
Acurx Pharmaceuticals, Inc. reported Research And Development Expense of $1.83 million for the year ending 2025.
- Acurx Pharmaceuticals, Inc. showed a decrease of -66.1% in Research And Development Expense from 2024 to 2025.
- This data is from Acurx Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Acurx Pharmaceuticals, Inc.'s Research And Development Expense has declined by 16.7%.
- Historical annual values: Fiscal year 2025: $1.83 million | Fiscal year 2024: $5.40 million | Fiscal year 2023: $6.04 million | Fiscal year 2022: $4.75 million | Fiscal year 2021: $2.03 million | Fiscal year 2020: $2.20 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: